SARS-CoV-2 vaccination and myocarditis in a highly vaccinated New Zealand population

Back

ESC Professional Premium Access

SARS-CoV-2 vaccination and myocarditis in a highly vaccinated New Zealand population

Session: Myocarditis: still many open questions

Topic: Myocarditis

Speaker: Doctor C. Greer (Christchurch, NZ)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Charlotte Greer

University of Otago Christchurch, Christchurch (New Zealand)

0 follower

5 more presentations in this session

Impact of myocardial injury on mortality and adverse events in hospitalized patients with influenza: a prospective cohort study

Speaker: Doctor A. Valotta (Lugano, CH)

Prevalence and characteristics of abnormalities on cardiac MRI in unselected patients after recovery from acute SARS-CoV-2 infection and correlation with markers of immunity and coagulation: the Study

Speaker: Doctor R. Colleran (Dublin 7, IE)

Prognostic implication of neutrophil-lymphocyte ratio (NLR) in myocarditis: results from a multicentre, multinational study.

Speaker: Doctor M. Sadler (London, GB)

Genetic characterization of biopsy-proven myocarditis: a pilot study

Speaker: Doctor M. Bueno Marinas (Padova, IT)

Role of immunosuppression in patients with lymphocytic myocarditis and myocardial parvovirus B19 with or without human herpesvirus 6 co-presence

Speaker: Doctor A. Elsanhoury (Berlin, DE)

Access the full session

Myocarditis: still many open questions

Speakers: Doctor C. Greer, Doctor A. Valotta, Doctor R. Colleran, Doctor M. Sadler, Doctor M. Bueno Marinas...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources